Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain

被引:27
|
作者
Gonzalez-Escalada, Alba [1 ,2 ]
Garcia-Garcia, Laura [1 ,2 ]
Viguera-Ester, Pablo [1 ,2 ]
Marin-Garcia, Patricia [1 ,2 ]
Garcia, Jesus [3 ]
Gil-de-Miguel, Angel [1 ,2 ]
Gil-Prieto, Ruth [1 ,2 ]
机构
[1] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Madrid, Spain
[2] Univ Rey Juan Carlos, Dept Immunol & Med Microbiol, Madrid, Spain
[3] Fuenlabrada Univ Hosp, Microbiol Unit, Madrid, Spain
关键词
seroprevalence; young adults; measles; rubella; mumps; B; Pertussis; Varicela-Zoster Virus; BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; VIRUS; POPULATION; CATALONIA; COUNTRIES; ASSAYS; STANDARDIZATION; EPIDEMIOLOGY; PERFORMANCE;
D O I
10.4161/hv.25127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In recent years, there has been an increase in the number of cases of certain immunopreventable diseases in our country. A high proportion of these have been recorded among the young adult population. The aim of this study was to determine the seroprevalence of antibodies against immunopreventable diseases with the greatest health impacts on the young adult population (19-39 y of age) in Madrid. We collected a total of 1,153 serum samples from healthy volunteers undergoing routine medical visits and used ELISA to determine the presence of IgG antibodies against measles, rubella, mumps, and varicella zoster, as well as Bordetella pertussis. The Pearson's 2 test was used to compare prevalences, the Mann-Whitney U test was used to compare means, and the Kruskal-Wallis test was applied for variables with more than 2 categories. Statistical significance was achieved with p values of < 0.05. The global prevalence of antibodies was 92.1% for measles, 94.4% for rubella, 88.3% for mumps, 92.8% for varicella zoster, and 70.2% for B. pertussis. No statistically significant differences were found between genders. The prevalence of antibodies against measles was more than 95% in the group of individuals born after 1986, and the percentage of individuals susceptible to rubella was less than 5% in women born after 1986. In spite of adequate vaccination coverage, in our region, a population of young adults exists who have not achieved the objectives of the WHO for the elimination of measles and congenital rubella syndrome.
引用
收藏
页码:1918 / 1925
页数:8
相关论文
共 50 条
  • [41] Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life
    Desgrandchamps, D
    Schaad, UB
    Glaus, J
    Tusch, G
    Heininger, U
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (41) : 1479 - 1486
  • [42] Comparison of a new multiplex BioPlex® 2200 assay for the detection of measles, mumps, and varicella-zoster virus IgM antibodies in human specimens
    King, D.
    Del Rosario, C. Renato
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S50 - S50
  • [43] Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan
    Asari, S
    Deguchi, M
    Tahara, K
    Taniike, M
    Toyokawa, M
    Nishi, I
    Watanabe, M
    Iwatani, Y
    Makimoto, K
    AMERICAN JOURNAL OF INFECTION CONTROL, 2003, 31 (03) : 157 - 162
  • [44] Are measles, mumps and rubella a public health issue in young adults? Results from a seroprevalence survey in university students in Italy
    Langiano E.
    Ferrara M.
    La Torre G.
    Lanni L.
    Atrei P.
    Martellucci G.
    De Vito E.
    Journal of Public Health, 2010, 18 (5) : 443 - 451
  • [45] Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots
    Higgins, Stephen G.
    Hoff, Nicole A.
    Gadoth, Adva
    Fusellier, Andrew
    Mukadi, Patrick
    Alfonso, Vivian
    Randall, Christina
    Ashbaugh, Hayley
    Poncheri, Melanie
    Doshi, Reena H.
    Gerber, Sue
    Budd, Roger
    Wolfert, Robert
    Williams, Russell
    Okitolonda-Wemakoy, Emile
    Muyembe-Tamfum, Jean-Jacque
    Rimoin, Anne W.
    MSPHERE, 2019, 4 (04):
  • [46] IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
    Brettschneider, Johannes
    Tumani, Hayrettin
    Kiechle, Ulrike
    Muche, Rainer
    Richards, Gayle
    Lehmensiek, Vera
    Ludolph, Albert C.
    Otto, Markus
    PLOS ONE, 2009, 4 (11):
  • [47] Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy
    Kumakura, S.
    Shibata, H.
    Onoda, K.
    Nishimura, N.
    Matsuda, C.
    Hirose, M.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (01): : 12 - 19
  • [48] Evaluation of three different sample populations on a new multiplex BioPlex® 2200 assay for the detection of measles, Mumps, and Varicella-Zoster virus IgM antibodies
    King, D.
    Del Rosario, R.
    Tatyosian, C.
    Todd, C.
    Flanagan, J.
    Vogel, J.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 82 : S50 - S51
  • [49] Effect of vaccine program on IgG antibody titers for measles, rubella, varicella, and mumps in young adults in Japan: Survey between 2018 and 2021
    Miyazaki, Haruko
    Yamanaka, Gaku
    Furukawa, Keitaro
    Ichiki, Masahiko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (10) : 1410 - 1414
  • [50] Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel
    Levine, Hagai
    Zarka, Salman
    Ankol, Omer E.
    Rozhavski, Vladi
    Davidovitch, Nadav
    Aboudy, Yair
    Balicer, Ran D.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1400 - 1405